Medical breakthroughs often happen in unexpected parts of the country.
But when I meet Doctor Esther Moss in one of the many buildings that make up Leicester Royal Infirmary, I am surprised how she seems to downplay this latest finding.
“It’s a whole team effort,” she tells me.
We walk into a small unassuming gynaecology clinic room. There at the back of the room, I see the chair that, I’ve been told, most patients dread. The gynae chair.
Dr Moss made it her mission eight years ago to come up with a test for her patients who were worried their endometrial cancer had returned post treatment.
“Many patients find speculum and pelvic examination very challenging at the best of times, let alone after cancer surgery,” she says.
The ECctDNA test, which looks for fragments of cancer in patients’ blood, makes it easier and far less invasive to detect whether cancer has recurred, removing the need for patients to have to undergo invasive physical examinations, scans and potentially uncomfortable biopsies.
Translate This Article
